Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...
Researchers have identified a promising way to predict bloodstream infections in children with high-risk leukemia days before the infection would be diagnosed using current standards of care. The test ...
Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results